238 related articles for article (PubMed ID: 36123621)
1. Joint models for dynamic prediction in localised prostate cancer: a literature review.
Parr H; Hall E; Porta N
BMC Med Res Methodol; 2022 Sep; 22(1):245. PubMed ID: 36123621
[TBL] [Abstract][Full Text] [Related]
2. A Personalized Clinical Dynamic Prediction Model to Characterize Prognosis for Patients With Localized Prostate Cancer: Analysis of the CHHiP Phase 3 Trial.
Parr H; Porta N; Tree AC; Dearnaley D; Hall E
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1055-1068. PubMed ID: 36822374
[TBL] [Abstract][Full Text] [Related]
3. Illustration of association between change in prostate-specific antigen (PSA) values and time to tumor status after treatment for prostate cancer patients: a joint modelling approach.
Liaqat M; Kamal S; Fischer F
BMC Urol; 2023 Dec; 23(1):202. PubMed ID: 38057759
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach.
Proust-Lima C; Taylor JM
Biostatistics; 2009 Jul; 10(3):535-49. PubMed ID: 19369642
[TBL] [Abstract][Full Text] [Related]
5. Joint modelling of longitudinal and multi-state processes: application to clinical progressions in prostate cancer.
Ferrer L; Rondeau V; Dignam J; Pickles T; Jacqmin-Gadda H; Proust-Lima C
Stat Med; 2016 Sep; 35(22):3933-48. PubMed ID: 27090611
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical Trial.
Finelli A; Beer TM; Chowdhury S; Evans CP; Fizazi K; Higano CS; Kim J; Martin L; Saad F; Saarela O
JAMA Netw Open; 2021 Jun; 4(6):e2112426. PubMed ID: 34129025
[TBL] [Abstract][Full Text] [Related]
7. Bayesian Individual Dynamic Predictions with Uncertainty of Longitudinal Biomarkers and Risks of Survival Events in a Joint Modelling Framework: a Comparison Between Stan, Monolix, and NONMEM.
Riglet F; Mentre F; Veyrat-Follet C; Bertrand J
AAPS J; 2020 Feb; 22(2):50. PubMed ID: 32076894
[TBL] [Abstract][Full Text] [Related]
8. Joint latent class models for longitudinal and time-to-event data: a review.
Proust-Lima C; Séne M; Taylor JM; Jacqmin-Gadda H
Stat Methods Med Res; 2014 Feb; 23(1):74-90. PubMed ID: 22517270
[TBL] [Abstract][Full Text] [Related]
9. Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer: a systematic review.
Sutcliffe P; Hummel S; Simpson E; Young T; Rees A; Wilkinson A; Hamdy F; Clarke N; Staffurth J
Health Technol Assess; 2009 Jan; 13(5):iii, xi-xiii 1-219. PubMed ID: 19128541
[TBL] [Abstract][Full Text] [Related]
10. Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance.
Tomer A; Nieboer D; Roobol MJ; Bjartell A; Steyerberg EW; Rizopoulos D;
BJU Int; 2021 Jan; 127(1):96-107. PubMed ID: 32531869
[TBL] [Abstract][Full Text] [Related]
11. Nonlinear joint models for individual dynamic prediction of risk of death using Hamiltonian Monte Carlo: application to metastatic prostate cancer.
Desmée S; Mentré F; Veyrat-Follet C; Sébastien B; Guedj J
BMC Med Res Methodol; 2017 Jul; 17(1):105. PubMed ID: 28716060
[TBL] [Abstract][Full Text] [Related]
12. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
13. Individualized dynamic prediction of prostate cancer recurrence with and without the initiation of a second treatment: Development and validation.
Sène M; Taylor JM; Dignam JJ; Jacqmin-Gadda H; Proust-Lima C
Stat Methods Med Res; 2016 Dec; 25(6):2972-2991. PubMed ID: 24847900
[TBL] [Abstract][Full Text] [Related]
14. Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes.
Cooperberg MR; Brooks JD; Faino AV; Newcomb LF; Kearns JT; Carroll PR; Dash A; Etzioni R; Fabrizio MD; Gleave ME; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Lin DW; Zheng Y
Eur Urol; 2018 Aug; 74(2):211-217. PubMed ID: 29433975
[TBL] [Abstract][Full Text] [Related]
15. Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.
Vickers AJ; Savage C; O'Brien MF; Lilja H
J Clin Oncol; 2009 Jan; 27(3):398-403. PubMed ID: 19064972
[TBL] [Abstract][Full Text] [Related]
16. Prostate specific antigen only progression of prostate cancer.
Moul JW
J Urol; 2000 Jun; 163(6):1632-42. PubMed ID: 10799151
[TBL] [Abstract][Full Text] [Related]
17. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases.
Moul JW; Connelly RR; Lubeck DP; Bauer JJ; Sun L; Flanders SC; Grossfeld GD; Carroll PR
J Urol; 2001 Oct; 166(4):1322-7. PubMed ID: 11547066
[TBL] [Abstract][Full Text] [Related]
18. Real-time individual predictions of prostate cancer recurrence using joint models.
Taylor JM; Park Y; Ankerst DP; Proust-Lima C; Williams S; Kestin L; Bae K; Pickles T; Sandler H
Biometrics; 2013 Mar; 69(1):206-13. PubMed ID: 23379600
[TBL] [Abstract][Full Text] [Related]
19. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
20. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model.
Spiess PE; Levy DA; Mouraviev V; Pisters LL; Jones JS
BJU Int; 2013 Aug; 112(4):E256-61. PubMed ID: 23469778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
